Abstract
The management of locally advanced rectal cancer underwent a paradigm shift from the historical practice of upfront surgery to the use of neoadjuvant chemoradiotherapy followed by surgery after two sentinel observations, namely, the high rates of local recurrence rates after the former and the long-lasting success of the latter in terms of reducing local recurrence rates in randomized controlled trials.
Original language | English |
---|---|
Pages (from-to) | 303-305 |
Number of pages | 3 |
Journal | Future Oncology |
Volume | 13 |
Issue number | 4 |
DOIs |
|
Publication status | Published - Feb 2017 |
Keywords
- rectal cancer
- Neoadjuvant therapy
- surgery
- pathology
- MRI
- survival
- meta-analysis
- research
- randomized controlled trial
- outcomes
- mortality
- fibrosis
- morbidity